www.chrisbojrabmd.com


Transparency Statement/Disclosure of Potential Conflicts of Interest

In the spirit of transparency and disclosure of my potential conflicts of interest, I would like to make you aware that I derive a portion of my income each year as a consultant for a number of pharmaceutical and educational companies.  I spend a good deal of my time traveling across the country lecturing to other healthcare professionals on the use of medications to treat certain conditions as well as speaking on certain disease states to professional and public audiences. I also consult with a variety of companies in several capacities including sales force training, speaker training for physicians and other healthcare professionals, and the development of scientific and marketing materials. I am compensated for this work according to the guidelines of Pharmaceutical Research and Manufacturers of America (PhRMA). I choose the medications and companies for whom I speak based on my clinical experience with the medications and my review of available scientific literature. I am only involved in educational and promotional activities for those medications which I use routinely in my practice. While I use nearly every available medication at some time, I frequently turn down offers from some companies whose medications I do not use as first line agents.

I am/have served as a member of the lecture bureau and/or as a consultant for the following companies (current companies in bold):
 
  • Allergan
  • Assurex
  • Eli Lilly & Company
  • Cephalon
  • Forest Pharmaceuticals
  • Glaxo SmithKline
  • Janssen Pharmaceuticals
  • Jazz Pharmaceuticals
  • Medical World Conferences
  • Merck
  • Myriad Pharmaceuticals
  • Nestle Health Sciences
  • Neuroscience Education Institute
  • Otsuka
  • Pan American Labs
  • Pfizer
  • PsychU
  • Sepracor
  • Spektron Systems (consultant & investor)
  • Sunovion
  • Takeda Pharmaceuticals´╗┐
  • Teva Pharmaceuticals
  • Wyeth